Author:
Tiplica George-Sorin,Tschachler Erwin
Publisher
Springer International Publishing
Reference42 articles.
1. Centers for Disease Control and Prevention. Sexually transmitted disease surveillance, 2010. Atlanta: CDC; Department of Health and Human Services; 2011.
2. Wolf K, Betts HJ, Chellas-Géry B, Hower S, Linton CN, Fields KA. Treatment of Chlamydia trachomatis with a small molecule inhibitor of the Yersinia type III secretion system disrupts progression of the chlamydial developmental cycle. Mol Microbiol. 2006;61(6):1543–55.
3. Belland RJ, Zhong G, Crane DD, Hogan D, Sturdevant D, Sharma J, et al. Genomic transcriptional profiling of the developmental cycle of Chlamydia trachomatis. Proc Natl Acad Sci U S A. 2003;100:8478–83.
4. Caldwell HD, Kromhout J, Schachter J. Purification and partial characterization of the major outer membrane protein of Chlamydia trachomatis. Infect Immun. 1981;31(3):1161–76.
5. van de Laar MJ, Morré SA. Chlamydia: a major challenge for public health. Euro Surveill. 2007;12:El–2.